Lulla PD, Naik S, Vasileiou S, et al. Clinical effects of administering leukemia-specific donor T cells to patients with AML/MDS after allogeneic transplant. Blood. 2021;137(19):2585-2597.

On page 2596, in the second paragraph of “Acknowledgments,” the grant number (RP200584) of the CPRIT Early Career Clinical Investigator Award to Premal D. Lulla was omitted. In the conflict-of-interest disclosure, the statement “Baylor College of Medicine has a financial relationship with Marker Therapeutics” was omitted. The errors have been corrected in the online version of the article.